about
Methods of blinding in reports of randomized controlled trials assessing pharmacologic treatments: a systematic reviewThe PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaborationLikely country of origin in publications on randomised controlled trials and controlled clinical trials during the last 60 yearsDesign paper: The CapOpus trial: a randomized, parallel-group, observer-blinded clinical trial of specialized addiction treatment versus treatment as usual for young patients with cannabis abuse and psychosisRhodiola rosea for physical and mental fatigue: a systematic reviewWhy most published research findings are false: author's reply to Goodman and GreenlandThrombolysis for acute upper extremity deep vein thrombosisNon-invasive positive pressure ventilation for acute asthma in childrenSulphonylurea monotherapy for patients with type 2 diabetes mellitusTargeting intensive glycaemic control versus targeting conventional glycaemic control for type 2 diabetes mellitusNon-acute percutaneous coronary intervention versus medical therapy in patients with ischaemic heart diseaseMammario-arterial anastomosis versus aorto-arterial anastomosis as proximal anastomotic sites in coronary artery bypass surgery for patients with multivessel diseaseEnteral nutrition formulations for acute pancreatitisSurgical portosystemic shunts versus transjugular intrahepatic portosystemic shunt for variceal haemorrhageNutrition support in hospitalised adults at nutritional riskTranscatheter versus optimal medical treatment and surgical aortic valve replacement for aortic valve stenosisMammalian target of rapamycin inhibitors for heart transplant patientsAntibody induction versus corticosteroid induction for liver transplant recipientsPulmonary perfusion versus no pulmonary perfusion during cardiopulmonary bypass for cardiac surgeryAntibody induction versus placebo, no induction, or another type of antibody induction for liver transplant recipientsAntibody induction versus corticosteroid induction for liver transplant recipientsSulphonylurea monotherapy for patients with type 2 diabetes mellitusDrugs improving insulin resistance for non-alcoholic fatty liver disease and/or non-alcoholic steatohepatitisTranscatheter versus optimal medical treatment and surgical aortic valve replacement for aortic valve stenosisPharmacological interventions for the primary prevention of gallbladder stones in adultsDiets for primary prevention of gallbladder stones in adultsNew treatments compared to established treatments in randomized trialsTerlipressin for hepatorenal syndromeNon-operative versus operative treatment for blunt pancreatic trauma in childrenContinuous passive motion following total knee arthroplasty in people with arthritisNon-operative versus operative treatment for grade III to V blunt pancreatic trauma in childrenCalcineurin inhibitor minimisation versus continuation of calcineurin inhibitor treatment for liver transplant recipientsBanding ligation versus beta-blockers for primary prevention in oesophageal varices in adultsOptimum duration of regimens for Helicobacter pylori eradicationImmunosuppressive T-cell antibody induction for heart transplant recipientsUrsodeoxycholic acid for primary biliary cirrhosisAntibody induction therapy for lung transplant recipientsEnteral nutrition formulations for acute pancreatitisTargeting intensive glycaemic control versus targeting conventional glycaemic control for type 2 diabetes mellitusTacrolimus versus cyclosporin as primary immunosuppression for lung transplant recipients
P2860
Q21090146-67127DDB-FE40-4A3C-9FFA-945C84E38843Q21092360-912F95D7-5901-48C9-B554-53971DC1F0E4Q21203726-7130E3FB-1F23-40A2-980F-5458360A27ABQ21203727-835F4EAE-1576-4F64-9777-543C02F017BDQ21254682-3E6A9E73-7C14-453E-863C-D74A7CB6CF1FQ21563418-EBD85C9A-F794-4294-93C5-B8FF17338084Q24185948-74392DF2-5D7B-4E6B-AB01-E13640B65395Q24186648-04007C5F-B1E0-475E-9D04-E1C31D3EF374Q24186660-715E8283-095E-482E-87F2-F3CE4E4F4B6BQ24186667-2AE4C5BC-88A9-4DC0-85FA-93115EF816ABQ24186673-B263DC1B-D32F-416C-8C67-C4C69657BF41Q24186682-B78D030B-EE20-439F-A7B8-459FBCAFC63DQ24187179-D509618B-7A81-43A9-84E7-3EC6EFC1F63BQ24187528-EC92601B-7D40-48E8-84E1-3D2293796170Q24187602-392BA6E3-BA4A-4560-8D36-3E7CEAB61655Q24188266-724E4BB3-4EFA-4ABE-857E-78802405A138Q24194002-E73A8CA9-8DB6-496C-8C5D-9162F1C5A2D2Q24194518-295C8615-4823-4107-B1E9-2F02A370B740Q24194915-09AD3ACF-D729-4968-813A-422E2FBE8751Q24197745-AA55D197-5082-46F3-A79A-4EF0D6241676Q24197859-7E4B0AC8-4107-4B52-B1CC-2149C98DBC24Q24197884-4493EF94-4A1B-4DF2-A523-A6AA6EDF9C4AQ24198072-31FF6FD5-C731-4EB4-BEF7-78290AC03A14Q24198166-7B8152BE-75AA-45A1-9E2C-95C90555B900Q24198275-28BCD558-1B7B-4A4A-8E91-315CD47C9059Q24198839-E4C2B478-AB2D-431B-A883-7630588624DFQ24198868-670DFEFB-574E-4D1B-8E1B-AADFE34D432CQ24200336-71B8DD39-BE66-4FFB-B730-1D9F1C314346Q24200411-40820C0B-8FE1-4BF0-A9DC-EA9D7FE1578FQ24200547-3BBCE44E-A624-4D9D-9BAC-CFB25905C699Q24200680-1F2E953D-45E3-465F-9C73-1B7839488255Q24201021-9CE18940-2B93-468C-97A9-4A964EB91084Q24201710-7EC4C5C0-E26B-4A94-B4C7-EA3D0FE22C96Q24201841-052E2019-427B-49F5-B227-072290095F1DQ24202021-5572A71E-412E-454F-A028-AB4ED2FE9161Q24202184-274E16A0-8567-402C-9A69-E50884602559Q24202331-AAEE5874-7E47-4FF7-B11E-4962785A9384Q24202368-ED6976D9-65A8-4403-9FBD-5F1BEEFD7EF0Q24202505-48781C43-78CF-4698-981E-CCD6BAC5E28CQ24202759-71A975F8-98A3-4CD3-8C1D-60DDB2496B85
P2860
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Bias in clinical intervention research.
@ast
Bias in clinical intervention research.
@en
type
label
Bias in clinical intervention research.
@ast
Bias in clinical intervention research.
@en
prefLabel
Bias in clinical intervention research.
@ast
Bias in clinical intervention research.
@en
P356
P1476
Bias in clinical intervention research
@en
P2093
Lise Lotte Gluud
P304
P356
10.1093/AJE/KWJ069
P407
P50
P577
2006-01-27T00:00:00Z